“EARLY DETERMINATION RISKS OF ATHEROSCLEROSIS IN THE PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE” (2025) International journal of medical sciences, 5(12), pp. 1019–1023. doi:10.55640/.